ClinicalTrials.Veeva

Menu

Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial (MID-ACT)

George Washington University (GW) logo

George Washington University (GW)

Status and phase

Not yet enrolling
Phase 3

Conditions

Pregnancy Related

Treatments

Dietary Supplement: Multiple Micronutrient Supplements with 45 mg of elemental iron
Dietary Supplement: Multiple Micronutrient Supplements with 60 mg of elemental iron
Dietary Supplement: Multiple Micronutrient Supplements with 30 mg of elemental iron

Study type

Interventional

Funder types

Other

Identifiers

NCT06069869
MID-ACT

Details and patient eligibility

About

This is an individually randomized cross-over trial to assess acceptability, preference, and perceived side effects of MMS formulations with 30 mg, 45 mg and 60 mg of iron.

Enrollment

156 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Attending first ANC visit at the study clinic
  • Pregnant women ≤ 15 weeks of gestation
  • Aged ≥ 18 years
  • Intending to stay in Dar es Salaam for the duration of study
  • Provides informed consent

Exclusion criteria

  • Severe anemia (defined as Hb <8.5 g/dL per Tanzania standard of care)
  • Sickle cell disease (SS and SC) and hemoglobin C disease (CC) as tested by HemoTypeSC
  • Concurrent participation in other nutritional supplementation trial

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

156 participants in 6 patient groups

MM 30mg; then MMS 45mg; then MMS 60mg
Experimental group
Description:
Participants first receive MMS with 30 mg for one month, then MMS with 45 mg of iron for one month, then MMS with 60 mg of iron for one month
Treatment:
Dietary Supplement: Multiple Micronutrient Supplements with 30 mg of elemental iron
Dietary Supplement: Multiple Micronutrient Supplements with 60 mg of elemental iron
Dietary Supplement: Multiple Micronutrient Supplements with 45 mg of elemental iron
MM 30mg; then MMS 60mg; then MMS 45mg
Experimental group
Description:
Participants first receive MMS with 30mg for one month, then MMS with 60mg of iron for one month, then MMS with 45 mg of iron for one month
Treatment:
Dietary Supplement: Multiple Micronutrient Supplements with 30 mg of elemental iron
Dietary Supplement: Multiple Micronutrient Supplements with 60 mg of elemental iron
Dietary Supplement: Multiple Micronutrient Supplements with 45 mg of elemental iron
MM 45mg; then MMS 30mg; then MMS 60mg
Experimental group
Description:
Participants first receive MMS with 45 mg for one month, then MMS with 30 mg of iron for one month, then MMS with 60 mg of iron for one month
Treatment:
Dietary Supplement: Multiple Micronutrient Supplements with 30 mg of elemental iron
Dietary Supplement: Multiple Micronutrient Supplements with 60 mg of elemental iron
Dietary Supplement: Multiple Micronutrient Supplements with 45 mg of elemental iron
MM 45 mg; then MMS 60mg; then MMS 30mg
Experimental group
Description:
Participants first receive MMS with 45 mg for one month, then MMS with 60 mg of iron for one month, then MMS with 30 mg of iron for one month
Treatment:
Dietary Supplement: Multiple Micronutrient Supplements with 30 mg of elemental iron
Dietary Supplement: Multiple Micronutrient Supplements with 60 mg of elemental iron
Dietary Supplement: Multiple Micronutrient Supplements with 45 mg of elemental iron
MM 60mg; then MMS 30mg; then MMS 45mg
Experimental group
Description:
Participants first receive MMS with 60 mg for one month, then MMS with 30 mg of iron for one month, then MMS with 45 mg of iron for one month
Treatment:
Dietary Supplement: Multiple Micronutrient Supplements with 30 mg of elemental iron
Dietary Supplement: Multiple Micronutrient Supplements with 60 mg of elemental iron
Dietary Supplement: Multiple Micronutrient Supplements with 45 mg of elemental iron
MM 60mg; then MMS 45mg; then MMS 30mg
Experimental group
Description:
Participants first receive MMS with 60 mg for one month, then MMS with 45 mg of iron for one month, then MMS with 30 mg of iron for one month
Treatment:
Dietary Supplement: Multiple Micronutrient Supplements with 30 mg of elemental iron
Dietary Supplement: Multiple Micronutrient Supplements with 60 mg of elemental iron
Dietary Supplement: Multiple Micronutrient Supplements with 45 mg of elemental iron

Trial contacts and locations

0

Loading...

Central trial contact

Emily R Smith, ScD, MPH; Christopher R Sudfeld, ScD, ScM

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems